Therapy News and Research

RSS

Men with erectile dysfunction (ED) are 38 percent more likely to have hypertension

This statistical analysis is the largest epidemiological study to confirm this link, and the first to compare men with ED - and those without - for hypertension

10 May 2004

Female incontinence and sexual dysfunction questions answered

Kristene Whitmore, M.D., an AUA spokesperson and director of the Pelvic Floor Institute at the Graduate Hospital in Philadelphia, will be on hand to answer reporter questions about incontinence and female sexual dysfunction on Sunday, May 9, 2004 at 3:00 p.m.

10 May 2004

New chink in the cellular armor of tuberculosis (TB) and leprosy

The family of bacteria that causes tuberculosis (TB) and leprosy are notoriously sturdy. And although the diseases they cause have been held in check for the past 50 years by antibiotics, some strains are becoming increasingly resistant to existing therapy.

10 May 2004

Prostatectomy may decrease male orgasmic quality

The first longitudinal study of male orgasmic quality following radical retropubic prostatectomy (RRP) found that some men experience decreased orgasmic quality.

8 May 2004

New way by which cells can become cancerous may solve mystery with lung cancer

Researchers at The University of Texas M. D. Anderson Cancer Center are describing an entirely new way by which cells can become cancerous. And they say their finding provides an answer to a mystery in lung and other cancers.

8 May 2004

Researchers find an entirely new way by which cells can become cancerous

Finding provides an answer to a mystery in lung and other cancers: why a potent tumor suppressor gene called FUS1 functions as it should, yet none of the protein it produces can be found anywhere in a cancer cell.

6 May 2004

Heart pumps better than medical therapy in keeping heart failure patients alive

Left ventricular assist devices (LVADs) – heart pumps – worked better than medical therapy in keeping seriously ill congestive heart failure patients alive, despite an increased risk of neurological complications, researchers report in today’s rapid access issue of Circulation: Journal of the American Heart Association.

6 May 2004

Study shows Chromium Picolinate and Biotin Combination significantly lowers coronary risk factors in people with Type 2 Diabetes

Results of a new double-blind, placebo-controlled, randomized clinical study show that daily nutritional supplementation with a combination of chromium picolinate and biotin (marketed as Diachromeä) significantly improved coronary risk factors in people with type 2 diabetes.

6 May 2004

A second-generation targetted antibody for potential cancer therapy

The overproduction, or 'overexpression', of the epidermal growth factor receptor (EGFR) is one of the most common aberrations in cancer, and subsequently agents that inhibit EGFR are among the most hotly-pursued potential products in the pharmaceutical industry.

6 May 2004

Ritalin drug used to treat hyperactive children boosts the potency of Parkinson's drug levodopa

A well-known drug used to treat hyperactive children boosts the potency of another drug that reduces Parkinson's disease symptoms, an Oregon Health & Science University study has found.

6 May 2004

Weight loss and exercise regime helps osteoarthritis

A combination of moderate weight loss and exercise is an effective treatment for overweight adults with osteoarthritis of the knee, according to new research from Wake Forest University published in the May issue of the journal Arthritis & Rheumatism.

6 May 2004

Cervical Dysplasia treatment linked to water breaking too early

Two treatments for removing precancerous tissue from the cervix are associated with an increased risk of preterm delivery (delivery before 37 weeks gestation) caused by the pregnancy complication known as preterm premature rupture of membranes (PPROM).

5 May 2004

Study sheds new light on children with a severe form of acute lymphoblastic leukemia

A new international study of children with a severe form of acute lymphoblastic leukemia (ALL) shows that certain chromosome losses can signal an especially poor response to therapy, but that other chromosome abnormalities have no effect on treatment survival.

5 May 2004

World's first gene therapy trial aimed at preventing cancer

The concept seems straightforward. If, at its heart, cancer is a disease of genes, then giving patients new genes should disarm cancer. Such treatment would replace missing or faulty genes that keep cell growth in check, or would flush the body with "super genes" that could attack and destroy cancer.

5 May 2004